Actavis

Latest Articles

Actavis's Brent Saunders Is Pharma's Best-Looking CEO

Editors March 12, 2015

2015-03-anne-szustek-ceo-interview-brenton-saunders-large.jpg

Actavis CEO Brent Saunders Has a Vision for Growth

Anne Szustek

2015-12-anne-szustek-deals-of-the-year-allergan-pfizer-large.jpg

Allergan-Pfizer Merger Gives Pharma a Growth Injection

Anne Szustek

Conatus Capital Raises Funds for Long-Only Fund

Stephen Taub

Daily Agenda: Gravity Returns to Chinese Stock Market

Andrew Barber

2014-12-nick-rockel-feature-deals-of-the-year-actavis-allergen-lg.jpg

Deals of the Year 2014: Actavis Realizes Bigger Pharma Ambitions

Anne Szustek

Funds Benefit from Merger-Happy Health Care Stocks

Stephen Taub

2016-05-jeff-ostrowski-golden-parachutes-mergers-and-acquisitions-lg.jpg

Golden Parachutes Leave Investors Fearing Conflict of Interest

Jeff Ostrowski

Lone Pine on the Double-Edged Sword of Low Rates

Stephen Taub

The Morning Brief: Snapchat on the Road to Raising $650 Million

Stephen Taub

Tiger Bloc’s Biggest Holdings: Actavis, CDK and JD.com

Stephen Taub

Viking Global Breaks with Tiger Cubs and Bets on Health Care

Stephen Taub

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

develop build:2025-12-17 Login